Atrin Pharmaceuticals' Unattributed Round

Atrin Pharmaceuticals raised a round of funding on April 30, 2015. Investors include Ben Franklin Technology Partners of Southeastern PA.

Atrin Pharmaceuticals is a dynamic biopharmaceutical firm focused on the discovery and development of proprietary medications. Atrin centers its research on modalities which treat cancers lacking effe…

Articles about Atrin Pharmaceuticals' Unattributed Round: